Since chemokine levels are elevated in the serum of RA patients, it is possible that syndecan-3 binding is saturated and addition of exogenous syndecan-3 could bind further free chemokines and limit their ability of recruiting leukocytes to inflamed sites. Here, SDC3 is linked to rheumatoid arthritis.